372 related articles for article (PubMed ID: 21690492)
21. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
22. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
23. Libman-Sacks endocarditis as the first manifestation of systemic lupus erythematosus in an adolescent, with a review of the literature.
Sharma J; Lasic Z; Bornstein A; Cooper R; Chen J
Cardiol Young; 2013 Feb; 23(1):1-6. PubMed ID: 22805592
[TBL] [Abstract][Full Text] [Related]
24. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases.
Chalvon NB; Costedoat-Chalumeau N; Pennaforte JL; Servettaz A; Boulagnon Rombi C; Gavand PE; Lekieffre M; Le Guern V; Morel N; Cohen Aubart F; Haroche J; Mathian A; Collet JP; Piette JC; Amoura Z; Orquevaux P
Rheumatology (Oxford); 2023 Feb; 62(2):707-715. PubMed ID: 35686908
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study.
Gawalkar AA; Bahl A; Ahluwalia J; Sood A; Sharma A; Sharma S; Dhir V
Lupus; 2020 Oct; 29(12):1503-1508. PubMed ID: 32752919
[TBL] [Abstract][Full Text] [Related]
26. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.
Herranz MT; Rivier G; Khamashta MA; Blaser KU; Hughes GR
Arthritis Rheum; 1994 Apr; 37(4):568-71. PubMed ID: 8147935
[TBL] [Abstract][Full Text] [Related]
27. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Riancho-Zarrabeitia L; Martínez-Taboada VM; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Mena Vázquez N; Calvo-Alén J; Menor Almagro R; Tomero Muriel E; Uriarte Isacelaya E; Boteanu A; Andres M; Freire González M; Santos Soler G; Ruiz-Lucea ME; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez J; Expósito L; Hernández Beriaín JA; Horcada L; Aurrecoechea E; Pego Reigosa JM
Clin Exp Rheumatol; 2021; 39(3):555-563. PubMed ID: 32828148
[TBL] [Abstract][Full Text] [Related]
28. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
[TBL] [Abstract][Full Text] [Related]
31. [Cerebral infarct in a patient with systemic lupus erythematosus. The presence of lupus anticoagulant and Libman-Sacks endocarditis].
Labarga Echeverría P; Antón Botella F; Pinilla Moraza J; Milazo Estefanía A
Med Clin (Barc); 1992 Jun; 99(2):75. PubMed ID: 1630185
[No Abstract] [Full Text] [Related]
32. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus.
Ruiz D; Oates JC; Kamen DL
Am J Med Sci; 2018 Mar; 355(3):293-298. PubMed ID: 29549933
[TBL] [Abstract][Full Text] [Related]
33. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?
Mok MY; Farewell VT; Isenberg DA
Ann Rheum Dis; 2000 Jun; 59(6):462-7. PubMed ID: 10834864
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and long-term outcomes of Libman-Sacks endocarditis in patients with systemic lupus erythematosus.
Yoo BW; Lee SW; Song JJ; Park YB; Jung SM
Lupus; 2020 Aug; 29(9):1115-1120. PubMed ID: 32536317
[TBL] [Abstract][Full Text] [Related]
37. [Systemic lupus erythematosus: valvular regurgitation and its relation to anticardiolipin antibodies].
Díaz RA; Athanassopoulos G; Nihoyannopoulos P
Rev Med Chil; 1993 Feb; 121(2):156-61. PubMed ID: 8303111
[TBL] [Abstract][Full Text] [Related]
38. Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus.
Appelgren D; Dahle C; Knopf J; Bilyy R; Vovk V; Sundgren PC; Bengtsson AA; Wetterö J; Muñoz LE; Herrmann M; Höög A; Sjöwall C
Autoimmunity; 2018 Sep; 51(6):310-318. PubMed ID: 30369267
[TBL] [Abstract][Full Text] [Related]
39. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
40. [Libman-Sacks endocarditis].
Carrillo-Esper R; Carrillo-Córdova JR; Carrillo-Córdova LD; Carrillo-Córdova CA
Gac Med Mex; 2010; 146(1):67-9. PubMed ID: 20422938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
